期刊
MOVEMENT DISORDERS
卷 24, 期 15, 页码 2175-2186出版社
WILEY
DOI: 10.1002/mds.22589
关键词
apathy; hallucinations; depression; anxiety; Parkinson's disease
资金
- Novartis Pharmaceuticals
- GE Health
- Boehringer Ingelheim
- Osmotica Pharmaceuticals
Neuropsychiatric symptoms are common in Parkinson's disease, even at the earliest stages. and have important consequences for quality of life and daily functioning, are associated with increased carer burden and increased risk for nursing home admission. In addition to cognitive impairment, a wide range of neuropsychiatric symptoms have been reported. In this article, the epidemiology, clinical course, disagnosis, and management of some of the most common neuropsychiatric symptoms in PD are discussed: depression, anxiety, apathy, fatigue, and psychotic symptoms. Although much is known regarding the prevalence and course of these symptoms, the empirical evidence for how to manage these symptoms is limited at best. There is thus an urgent need for systematic studies for the pharmacological and non-pharmacological management of these symptoms. (C) 2009 Movement Disorder Society
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据